HEALTHX
Health X Platform Limited
Each stock's 10,000-path forecast, rendered as light.
Health X Platform Limited (HEALTHX) Stock Analysis & Case Study
Is HEALTHX a good buy? The data-driven verdict.
Health X Platform Limited (HEALTHX) trades at ₹307,on the numbers it tread carefully, a Downstox Snapshot Score of 33/100.
On the numbers, Health X Platform Limited (HEALTHX) tread carefully, a Downstox Snapshot Score of 33/100, weighing expensive at 201.0× earnings, ROE of 0.3%, a 55% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
HEALTHX fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How HEALTHX ranks against the 2,373 companies in our screener
- HEALTHX's market cap of 975 Cr ranks in the 39th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- HEALTHX's book value of ₹201 ranks in the 72nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- HEALTHX's promoter holding of 74.1% ranks in the 87th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- HEALTHX's 3-year profit (PAT) growth of 27.0% ranks in the 66th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- HEALTHX's 3-year revenue growth of 8.0% ranks in the 44th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- HEALTHX's debt-to-equity ratio of 0.04x is lower than 88% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is HEALTHX overvalued? HEALTHX P/E vs peers
HEALTHX trades at 201.0× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
HEALTHX share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of HEALTHX history (16%/yr drift, 38%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| HEALTHX 2027 | ₹199 | ₹321 | ₹519 | +5% |
| HEALTHX 2028 | ₹170 | ₹336 | ₹664 | +10% |
| HEALTHX 2029 | ₹153 | ₹352 | ₹808 | +15% |
| HEALTHX 2030 | ₹140 | ₹369 | ₹969 | +20% |
| HEALTHX 2031 | ₹131 | ₹386 | ₹1,133 | +26% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability HEALTHX goes up, or doubles?
The bull case for HEALTHX
- Health X Platform Limited is part of the nifty500 universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹808.
The bear case & risks
- HEALTHX's P/E of 201.0x is lower than 5% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- HEALTHX's return on equity of 0.3% ranks in the 12th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹153.
HEALTHX volatility & expected range, how bumpy is the ride?
Over the last 9.8 years HEALTHX compounded at 16%/year with annualized volatility of 38%. That volatility implies a 1-year 80% range of ₹199-₹519, the honest backbone behind any single price target.
HEALTHX price forecast, the full 60-month probability fan
HEALTHX price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds HEALTHX hits common targets within the simulated horizon?
Full multi-horizon detail on the HEALTHX price target & forecast page.
HEALTHX Piotroski F-Score: 4/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. HEALTHX scores 4/8, mixed financial health.
HEALTHX MTF margin & leverage across 2 brokers
Margin Trading Facility lets you buy HEALTHX with part of the capital. Lower margin % = higher leverage. Rates compared across 2 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Kotak Neo | 100.00% | 1.0× |
| Share IndiaCHEAPEST | 32.96% | 3.0× |
Compare every broker on the HEALTHX MTF page.
About Health X Platform Limited: sector, index & market-cap context
Health X Platform Limited (HEALTHX) is a small-cap NSE-listed company, with a market capitalisation of ₹975 Cr. See more stocks on our screener.
How the HEALTHX Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Health X Platform Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
HEALTHX analysis, FAQs
Is Health X Platform Limited (HEALTHX) a good buy?
On the numbers, Health X Platform Limited (HEALTHX) tread carefully, a Downstox Snapshot Score of 33/100, weighing expensive at 201.0× earnings, ROE of 0.3%, a 55% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is HEALTHX overvalued or undervalued?
HEALTHX trades at 201.0× earnings, expensive versus the ~22× long-run Nifty average.
What is the HEALTHX share price target for 2031?
HEALTHX's probability-weighted 2031 median target is ₹386, with an 80% range of ₹131-₹1,133 (10,000-path Monte-Carlo).
What is the probability HEALTHX doubles in 5 years?
The modelled probability of HEALTHX reaching ₹613 (2×) within 5 years is 29%.
What is the bull case for HEALTHX?
Health X Platform Limited is part of the nifty500 universe with live, tracked fundamentals on Downstox.
What are the risks in HEALTHX?
HEALTHX's P/E of 201.0x is lower than 5% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. HEALTHX's return on equity of 0.3% ranks in the 12th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.